Abstract
In the May 2013 AJHP supplement, Nutescu[1][1] cited an alarming number of serious adverse bleeding reactions to dabigatran compared with warfarin as reported to the MedWatch program in 2011.[2][2] Dabigatran was responsible for 3781 serious adverse bleeding events versus 1106 for warfarin, 2367
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
